EVLO - Evelo Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5200.37M
Enterprise Value 3102.04M
Trailing P/E N/A
Forward P/E 1-2.79
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.00
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.39

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-50.84%
S&P500 52-Week Change 30.90%
52 Week High 315.89
52 Week Low 34.90
50-Day Moving Average 36.87
200-Day Moving Average 38.01

Share Statistics

Avg Vol (3 month) 341.64k
Avg Vol (10 day) 332.61k
Shares Outstanding 532.04M
Float 11.8M
% Held by Insiders 12.68%
% Held by Institutions 185.20%
Shares Short (Jul 31, 2019) 41.53M
Short Ratio (Jul 31, 2019) 449.48
Short % of Float (Jul 31, 2019) 414.88%
Short % of Shares Outstanding (Jul 31, 2019) 44.79%
Shares Short (prior month Jun 28, 2019) 41.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-29.67%
Return on Equity (ttm)-54.72%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -73.16M
Net Income Avi to Common (ttm)-72.54M
Diluted EPS (ttm)-2.27
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)113.47M
Total Cash Per Share (mrq)3.54
Total Debt (mrq)15.14M
Total Debt/Equity (mrq)15.12
Current Ratio (mrq)11.86
Book Value Per Share (mrq)3.12

Cash Flow Statement

Operating Cash Flow (ttm)-61.47M
Levered Free Cash Flow (ttm)-42.52M